Directory

>

Elliott Sigal

avatar

Elliott Sigal

Board Member | Vir Biotechnology, Inc.

Roseville, California, United States

View contact details (it's free)

Elliott Sigal

Summary

Elliott Sigal is a prominent advisor and board member in the biotechnology sector, with a wealth of experience in biopharmaceuticals and clinical development. His career spans several high-profile roles, including serving as Chief Scientific Officer and Executive Vice President at Bristol Myers Squibb. Elliott has been instrumental in advancing drug discovery and development, particularly in the oncology space. He holds both an M.D. from the University of Chicago and a Ph.D. in Industrial Engineering from Purdue University, showcasing a unique blend of medical and engineering expertise. His leadership is recognized across multiple organizations, including Alnylam Pharmaceuticals and Vir Biotechnology. Elliott's commitment to innovation in life sciences is evident through his extensive board membership roles. He is passionate about regulatory affairs and the intricacies of FDA processes, which are crucial for bringing new therapies to market. With a career dedicated to improving patient outcomes, Elliott is a key figure in the evolution of modern medicine.

General

Generalist

Technical Background

Leadership Experience

Long-Term Tenure

Professional interests

Emerging Technologies

Leadership Development

Innovation

Organisational experience

Corporate Experience

Consulting Experience

Elliott Sigal

Work Experience

company logo

Board Member at

Alnylam Pharmaceuticals

August 2022 - Present

company logo

Board Member at

Vir Biotechnology, Inc.

July 2020 - Present

company logo

Co-Chair, Scientific Advisory Board at

Amgen, Inc.

October 2015 - Present

company logo

Board Member at

ADAPTIMMUNE LIMITED

September 2014 - November 2023

company logo

Board Member at

Surface Oncology Inc.

March 2018 - October 2023

company logo

Senior Advisor at

New Enterprise Associates (NEA)

January 2014 - March 2023

company logo

Board Member at

Melanoma Research Alliance

November 2013 - January 2023

company logo

Board Member at

Spark Therapeutics, Inc.

January 2014 - December 2019

company logo

Chief Scientific Officer and Executive Vice President at

Bristol Myers Squibb

October 2004 - June 2013

company logo

Board Member at

Bristol Myers Squibb

March 2011 - June 2013

Logos provided by Logo.dev

Elliott Sigal

Education

University of Chicago, Doctor Of Medicine (M.D.)

January 1977 - January 1981

Purdue University, Doctor Of Philosophy (Ph.D.)

January 1973 - January 1977

Purdue University, Bachelor Of Science (Bs)

January 1970 - January 1973

Purdue University, Master Of Science (Ms)

January 1973

Frequently Asked Questions about Elliott Sigal

What is Elliott Sigal email address?

Elliott Sigal's primary email address is ******@alnylam.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Elliott Sigal work for?

Elliott Sigal is a Board Member at Vir Biotechnology, Inc., a company specializing in Commercial physical research.

Where Elliott Sigal graduated from?

Elliott Sigal holds a degree in Medicine from University of Chicago.

How can I directly contact Elliott Sigal?

To contact Elliott Sigal directly, you can use the email address ******@alnylam.com. Complete contact information is available upon registration with Muraena.

Who is Elliott Sigal?

Elliott Sigal is a prominent advisor and board member in the biotechnology sector, with a wealth of experience in biopharmaceuticals and clinical development. His career spans several high-profile roles, including serving as Chief Scientific Officer and Executive Vice President at Bristol Myers Squibb. Elliott has been instrumental in advancing drug discovery and development, particularly in the oncology space. He holds both an M.D. from the University of Chicago and a Ph.D. in Industrial Engineering from Purdue University, showcasing a unique blend of medical and engineering expertise. His leadership is recognized across multiple organizations, including Alnylam Pharmaceuticals and Vir Biotechnology. Elliott's commitment to innovation in life sciences is evident through his extensive board membership roles. He is passionate about regulatory affairs and the intricacies of FDA processes, which are crucial for bringing new therapies to market. With a career dedicated to improving patient outcomes, Elliott is a key figure in the evolution of modern medicine.

Elliott`s contact details

mail

******@alnylam.com

******@curemelanoma.org

*************@bms.com

*************@adaptimmune.com

******@amgen.com

Colleagues

avatar
Nisha Birla

Vice President Procurement

avatar
Aine Hanly

Chief Technology Officer (CTO)

avatar
Andreza Oliveira

Vice President, Head of Clinical Operations

avatar
George Scangos

Chief Executive Officer

avatar
Brent Sabatini Cpa

Senior Vice President, Finance and Chief Accounting Officer

avatar
Lanzavecchia Antonio

Invernizzi Fellow, Human Immunology Program

avatar
Stacey Traviglia

Vice President, Analytical Development and Quality Control

avatar
Stephen Leanos

Vice President, Employment Law & Corporate Services

avatar
Erik Mogalian

Senior Vice President, Product Development

avatar
Mehrnaz Khossravi

Vice President, Pharmaceutical Development

View Contact details (it's free)
Request Profile Removal